Biogen Has Many `Exciting' Drugs in Pipeline: CEO

Biogen Has Many `Exciting' Drugs in Pipeline: CEO Play

Jan. 14 (Bloomberg) -- George Scangos, chief executive officer Biogen Idec Inc., talks about the company's multiple sclerosis drugs, pipeline and outlook. Scangos speaks with Erik Schatzker and Stephanie Ruhle on Bloomberg Television's "Market Makers." (Source: Bloomberg)

  • On Air Now

    PAID PROGRAMMING Watch Now

  • Next

    PAID PROGRAMMING

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

blog comments powered by Disqus